Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 3
2004 7
2005 5
2006 12
2007 5
2008 6
2009 10
2010 12
2011 19
2012 6
2013 17
2014 13
2015 11
2016 13
2017 12
2018 8
2019 10
2020 10
2021 11
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC, Hsiao JR, Jiang SS, Chang JY, Chu PY, Liu KJ, Fang HL, Lin LM, Chen HH, Huang YW, Chen YT, Tsai FY, Lin SF, Chuang YJ, Kuo CC. Tang YC, et al. Among authors: chang jy. Theranostics. 2021 Mar 11;11(11):5232-5247. doi: 10.7150/thno.53417. eCollection 2021. Theranostics. 2021. PMID: 33859744 Free PMC article.
Investigations of survivin: the past, present and future.
Cheung CH, Cheng L, Chang KY, Chen HH, Chang JY. Cheung CH, et al. Among authors: chang jy. Front Biosci (Landmark Ed). 2011 Jan 1;16(3):952-61. doi: 10.2741/3728. Front Biosci (Landmark Ed). 2011. PMID: 21196211 Free article. Review.
Aurora kinase inhibitors in preclinical and clinical testing.
Cheung CH, Coumar MS, Hsieh HP, Chang JY. Cheung CH, et al. Among authors: chang jy. Expert Opin Investig Drugs. 2009 Apr;18(4):379-98. doi: 10.1517/13543780902806392. Expert Opin Investig Drugs. 2009. PMID: 19335272 Review.
Survivin - biology and potential as a therapeutic target in oncology.
Cheung CH, Huang CC, Tsai FY, Lee JY, Cheng SM, Chang YC, Huang YC, Chen SH, Chang JY. Cheung CH, et al. Among authors: chang jy. Onco Targets Ther. 2013 Oct 16;6:1453-62. doi: 10.2147/OTT.S33374. Onco Targets Ther. 2013. PMID: 24204160 Free PMC article. Review.
MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY, Weng SM, Hsiao JR, Wu YY, Wu JE, Tung CH, Shen WL, Sun SF, Huang WT, Lin CY, Chen SH, Hong TM, Chen YL, Chang JY. Hsiao SY, et al. Among authors: chang jy. J Exp Clin Cancer Res. 2023 Feb 3;42(1):40. doi: 10.1186/s13046-023-02597-1. J Exp Clin Cancer Res. 2023. PMID: 36737832 Free PMC article.
Pharmacokinetics and protein binding of MPT0B292.
Tien YE, Li CJ, Liou JP, Chang JY, Huang JD. Tien YE, et al. Among authors: chang jy. Biopharm Drug Dispos. 2017 Jul;38(5):340-350. doi: 10.1002/bdd.2067. Epub 2017 Feb 27. Biopharm Drug Dispos. 2017. PMID: 28144964
190 results